The results confirmed a significant upregulation of SMARCD3 and TCN1 in ARDS samples (P < 0.05) (Figure 5G), consistent with the findings from training set 1, training set 2, and the validation set. The gene discussed is TCN1; the disease is acute respiratory distress syndrome.